Evidence map›Paper›PMID 39764271›Full record

ArticleClinical case reports2025

A Case Report of Membranoproliferative Glomerulonephritis: Infection-Related or Immune-Related?

Ayman Azhary, Mohammed Taha, Nooh Mohamed Hajhamed, Salahaldeen Ismail Mohammed, Nouh Saad Mohamed, Waleed Azhary Sir Alkhatim

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ayman AzharyDepartment of Medical Microbiology, Faculty of Medical Laboratory Sciences Omdurman Islamic University Khartoum Sudan.ORCID https://orcid.org/0000-0002-2804-1408
Mohammed TahaDepartment of Internal Medicine University of Gezira Gezira Sudan.
Nooh Mohamed HajhamedDepartment of Medical Microbiology, Faculty of Medical Laboratory Sciences Omdurman Islamic University Khartoum Sudan.ORCID https://orcid.org/0009-0003-3717-1815
Salahaldeen Ismail MohammedDepartment of Medical Microbiology, Faculty of Medical Laboratory Sciences Omdurman Islamic University Khartoum Sudan.
Nouh Saad MohamedMolecular Biology Unit Sirius Training and Research Centre Khartoum Sudan.ORCID https://orcid.org/0000-0001-6843-3361
Waleed Azhary Sir AlkhatimDepartment of Internal Medicine University of Sinnar Sudan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Membranoproliferative glomerulonephritis (MPGN) has previously been used as an umbrella term to describe a spectrum of hypocomplementemic glomerular diseases, which are rare causes of end stage kidney disease (ESKD). We present a 22-year-old man with a well-established medical history who had been complaining of 4 days of frothy dark urine, bilateral lower limb swelling, and puffiness on his face. For a month before his presentation, he had many bilateral skin lesions on his lower limbs that were leaking pus. Aside from the scars from the prior skin lesions, he had no other significant medical history, and his examination revealed no abnormalities. His tests revealed nephrotic range proteinuria with a normal renal profile, low serum albumin with low C3 and normal C4, and negative antinuclear antibodies (ANAs) by ELISA. After preliminary studies, we concluded that the condition was infection-related glomerulonephritis. Nevertheless, following renal biopsy, which revealed an MPGN pattern, and immunohistochemistry, which revealed a full house picture, we conducted a second ANA test using the more sensitive/broader spectrum IFA hep2 cell test, which showed a coarse speckled nuclear pattern with a significant titer (1/1000), as well as a negative line blot assay test using 15 distinct antigens. Following the modification of our diagnosis to lupus nephritis, the patient responded fairly well once we started him on an immunosuppressive drug. The patient was released from the hospital in a stable condition.

Indexed as

antinuclear antibodies (ANAs)end stage kidney diseaselupus nephritismembranoproliferative glomerulonephritis

Identifiers

PMID39764271
PMCPMC11702449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.